Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
Published on: November 21, 2023
US Views on New Vaccine Development and False Information After COVID-19
Gillian K SteelFisher1, Mary G Findling1, Hannah L Caporello1
1Gillian K. SteelFisher, PhD, MSc, is Principal Research Scientist and Director; Mary G. Findling, PhD, ScM, is Managing Director; and Hannah L. Caporello was Senior Research Projects Manager; all at the Harvard Opinion Research Program, Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA. Alyssa Boyea, MPH, CPH, is Director, Infectious Disease Preparedness, Association of State and Territorial Health Officials. Arlington, VA. Laura Espino is Program Director, National Public Health Information Coalition, Canton, GA. Jazmyne Sutton, PhD, is Research Director, SSRS, Glen Mills, PA.
None:
Vaccine innovations offer key tools to protect health, yet public views about vaccine development in the wake of COVID-19 are not well understood. We conducted a nationally representative survey of 1,632 US adults to examine public perceptions of vaccine development and false vaccine information that may shape views after the pandemic. The vast majority (81%) of adults thought vaccine development is "mostly a good thing," largely because vaccines protect the vulnerable and protect against severe illness (81% and 78%, respectively, among those who thought it was mostly a good thing). Most (78%) adults thought the spread of false vaccine information is a major problem, though few (26%) believed it is spread predominantly by people with bad intentions. Two-thirds (67%) said they had personally heard false information, but among those who gave examples, 31% provided statements that were about vaccines being beneficial, implying they believe vaccines are actually harmful. Findings suggest that public health leaders can build on largely positive public views of vaccine development, but should use caution when communicating about new vaccines and false information. It will be essential for leaders to acknowledge risks of new vaccines and avoid messages that seemingly denigrate people who might share false information.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
Related Concept Videos
Vaccinations
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Viral Recombination
Cross-reactivity